thursdays sp for pno, page-6

That run was linked to 3M showing great interest in OBJ, which it still does.
Hype sent the share in overdrive with very little information surrounding the hype.

Now that OBJ has just received the confirmation that the global leader GSK in oral health is going for an exclusive collaboration with OBJ to develop oral health products, the share lamely runs to 3 cents and crashes down to 2.4.
Go figure.

Our market loves hype more than concrete information at certain stages, the greatest winnings are often made by cashing in on the hype and not wait for the ann.

I desperately want to be proven wrong on this one, I have it as a 50 to 50 chance either way.

Regardless of this, PNO has a bright future and I will extend my portfolio vertically, liked that phrase from the annual report regarding Tripeptofen investment of PNO for the future, and adapted as my own strategy going forward with PNO.